Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10407938

[Tablets in stool? A common problem!].

L V Schuerch·J Nyfeler·G Holder·C Surber·W E Haefeli
View original source ↗Export metadata ↓

Abstract

Patients and their physicians are often thrown into doubt by the excretion of apparently intact tablets in stools after oral drug administration. This occurs whenever patients receive certain pharmaceutical forms designed to prolong the rate of drug release. The active compound is continuously released during intestinal passage of these pharmaceutical forms and their insoluble coats are visibly excreted into stools wholly or in part. The assumption that the drug was not released from the tablet in these cases is therefore erroneous and no further action is required.

Explore related subjects

CapsulesDelayed-Action PreparationsFecesHumansSolubilityTablets, Enteric-CoatedEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L V Schuerch, J Nyfeler, G Holder, C Surber, W E Haefeli. 1999-05-01. [Tablets in stool? A common problem!].. https://pubmed.ncbi.nlm.nih.gov/10407938/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules.

The main purpose of this work is to formulate benzathine penicillin G nanoemulsion and nanocapsules, to evaluate their physicochemical and stabilising characteristics, and to determine their antimicrobial activity and penicillin in vitro release kinetics. Nanoemulsions were produced by the spontaneous emulsification approach and nanocapsules of poly (D,L-lactic acid-co-glycolic acid) polymer (PLGA) were prepared by the method of interfacial deposition of a pre-formed polymer. A 207+/-8 nm mean diameter nanoemulsion formulation maintained stability for more than 5 months at 4 degrees C. Stable nanocapsules with 224+/-58 nm mean diameter were obtained, which remained stabilised over 120 days at 4 degrees C. The penicillin encapsulation ratio in the nanocapsules was 85%. The in vitro release profiles indicated that penicillin released from the nanoemulsion was similar to the one observed from nanocapsules. However it can be clearly deduced from the in vitro kinetic analysis that the antibiotic cannot be protected in colloidal delivery systems. Nevertheless, stable formulations obtained in this investigation supply a potential dosage form to encapsulate more easily soluble drugs.

Capsules↗
PubMed2000

Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study.

SLN with improved payloads and enhanced storage stability were investigated. Based on the experiences with solid lipid nanoparticles, a new type of solid lipid nanoparticle has been developed by incorporating triglyceride containing oils in the solid shell of the particle. The structure and mixing behaviour of these particles was characterised by DSC and (1)H-NMR. DSC yields information on the melting and crystallisation behaviour of the solid and liquid constituents of the particles. NMR is especially suited for the characterisation of the liquid oil domains inside the SLN. In this study a medium chain triglyceride oil was successfully incorporated in a matrix of a solid long chain glyceride (glyceryl behenate). The resulting particles were solid but the oil inside the particle remained in a liquid state. The relation between oil supplementation and melting point depression of glyceryl behenate proved to be linear. Mobility of the oil molecules inside the particles was considerably reduced compared to the emulsified oil. Moreover, two different chemical shifts for each of the lipid signals were observed indicating two different chemical environments. The experimental data is in line with a model describing uniform distribution of the oil molecules in the glyceryl behenate for low oil loads. However, at higher oil loads our data indicate the formation of oil clusters within the solid nanoparticle.

Capsules↗
PubMed2000

Microencapsulation of theophylline in whey proteins: effects of core-to-wall ratio.

Effects of core-to-wall ratio ranging from 1:1.5 to 5:1.5 on formation, properties and core release from whey protein-based microcapsules containing theophylline were investigated. Microcapsules were cross-linked by glutaraldehyde-saturated toluene (GAST) in an organic phase. Size distribution of microcapsules, core content and core retention were affected by core-to-wall ratio. Proportion of small capsules was inversely related to core-to-wall ratio. Core content in microcapsules ranged from 6.7 to 65.7% (w/w) and core retention ranged from 16.8 to 85.4%. Outer topography and inner structure of microcapsules were influenced by core-to-wall ratio. Core release into simulated intestinal- and gastric-fluids was influenced by a combined effect of type of dissolution medium and core-to-wall ratio, through its influence on size, core content and structure of microcapsules. Results indicated that in order to attain a desired core content and release profile, the ratio of core-to-wall components, in suspensions consisting of whey proteins and theophylline, has to be carefully considered and adjusted.

Capsules↗